BPC-157
vs
TB-500
Side-by-side comparison of mechanism, research, dosing, side effects, and pricing.
BPC-157
Pentadecapeptide derived from gastric juice protein. Extensively researched for tissue repair.
TB-500
Synthetic analog of naturally-occurring thymosin beta-4. Present in nearly all human cells.
Research base
200+ peer-reviewed studies. Strong animal models for tendon/ligament repair, GI healing, wound closure. Promising case reports.
80+ studies. Strong evidence for tissue repair, cardiac regeneration, anti-inflammatory effects.
How they work
Upregulates HGF (hepatocyte growth factor) and FGF signaling. Increases fibroblast proliferation and migration. Promotes angiogenesis.
Increases β-actin polymerization. Promotes cell migration and differentiation. Anti-inflammatory via IL-10 upregulation.
Protocols compared
What to expect
Generally well-tolerated. Rare reports of mild GI discomfort at high doses.
Effects typically observed 4-8 weeks in research models
Minimal. Some report mild headache. Very low toxicity profile.
2-6 weeks for observable effects in research
Price comparison
The honest verdict
Pick BPC-157 if: Strong standalone compound. Research-backed for tissue and tendon repair as a single agent.
Pick TB-500 if: Effective standalone for tissue repair research. Strong data on solo administration.
Why not both? Some researchers run them together. Check our Interaction Matrix to see if these compounds synergize or work independently.
